Dergiler / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2018 / Cilt: 23 - Sayı: 1

Klinik Örneklerden İzole Edilen Mycobacterium tuberculosis Kompleks İzolatlarının Birinci ve İkinci Seçenek Anti-Tüberküloz İlaçlara Karşı Duyarlılığın Sensititre MycoTB Plate Yöntemi ile Araştırılması

Investigation of Susceptibility of Mycobacterium tuberculosis Complex Strains Isolated from Clinical Samples Against the First and Second-Line Anti-tuberculosis Drugs by the Sensititre MycoTB Plate Method

Sayfa
31–38
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The Sensititre MycoTB Plate Method is a fast, reliable and practical method and can be used to determine the susceptibility of first and second-line anti-tuberculosis drugs.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: Phenotypic methods for drug susceptibility testing of Mycobacterium tuberculosis complex (MTC) to second-line drugs are not yet standardized.
📊
Temel Bulgular & Veri:The purpose of this study is to detect the susceptibility rates of MTC strains isolated from patients’ specimens for first and second-line anti-tuberculosis drugs.
💡
Sonuç & Katkı:The Sensititre MycoTB Plate Method is a fast, reliable and practical method and can be used to determine the susceptibility of first and second-line anti-tuberculosis drugs.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Introduction: Phenotypic methods for drug susceptibility testing of Mycobacterium tuberculosis complex (MTC) to second-line drugs are not yet standardized. The Sensititre MycoTB Plate is a microtiter plate containing lyophilized antibiotics and configured for determination of MIC to first and second-line anti-tuberculosis drugs. The purpose of this study is to detect the susceptibility rates of MTC strains isolated from patients’ specimens for first and second-line anti-tuberculosis drugs. Materials and Methods: This study included 50 MTC strains isolated from various clinical specimens. Out of the 50 strains, 38 were isolated from sputum, three from cerebrospinal fluid, three from bronchoalveolar lavage, and six from other samples in this study. The susceptibility of strains to anti-tuberculosis drugs were determined by the Sensititre MycoTB Plate Method. Thawed isolates were subcultured, and dilutions were inoculated into MycoTB wells. The results were read at days 7, 14 and 21. Results: At the end of study, out of 50 MTC isolates, 7 (14%) showed resistance to Isoniazid (INH), 5 (10%) to streptomycin (SM), 4 (8%) to ethambutol (EMB), 4 (8%) to ethionamide (ETH), 3 (6%) to rifampicin (RIF), 3 (6%) to rifabutin (RFB), 2 (4%) to kanamycin (KAN), 2 (4%) to ofloxacin (OFL), 2 (4%) to P-aminosalicyclic acid (PAS), 1 (2%) to moxiflocacin (MOX), and 1 (2%) to cycloserine (CYC). All strains were found sensitive to amikacin while 2 strains (4%) were identified as multidrug-resistant tuberculosis (MDR-TB). Thirty-five strains (70%) were sensitive to all drugs. Extensively drug resistant tuberculosis (XDR-TB) was not determined in this study. Conclusion: This is the first study that tests second line anti-tuberculosis drugs in our location and provides us valuable data regarding MDR-TB and XDR-TB rates. The Sensititre MycoTB Plate Method is a fast, reliable and practical method and can be used to determine the susceptibility of first and second-line anti-tuberculosis drugs.

🔖

Bu Makaleye Atıf Yap

ORHAN, F. K., AKTAŞ, A. E., YİĞİT, N. (2018). Klinik Örneklerden İzole Edilen Mycobacterium tuberculosis Kompleks İzolatlarının Birinci ve İkinci Seçenek Anti-Tüberküloz İlaçlara Karşı Duyarlılığın Sensititre MycoTB Plate Yöntemi ile Araştırılması. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 23 - Sayı: 1, 31–38. https://ajindex.com/articles/186357

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (6)

  1. World Health Organizatıon. Global Tuberculosis Report 2015. Geneva. http//WHO/HTM/TB/2014. Kiraz N. Antitüberküloz ilaçlara direnç mekanizmaları ve yeni ilaçlar. 21. Yüzyılda Tüberküloz Sempozyumu ve II. Tüberküloz Laboratuvar Tanı Yöntemleri Kursu. Samsun 2003:173-7. Çimen Özışık N. Çok ilaca dirençli tüberküloz hastalarında bactec ve agar proporsiyon yöntemleri ile saptanan etionamid direncinin klinik önemi. Uzmanlık tezi, 2006. Süreyyapaşa Göğüs ve Kalp Damar Hastalıkları Eğitim ve Araştırma Hastanesi, İstanbul.
  2. Şimşek H, Tarhan G, Cesur S. Çok ilaca dirençli Mycobacterium tuberculosis kompleks izolatlarında ikinci basamak antitüberküloz ilaç duyarlılıklarının E-test yöntemi ile değerlendirilmesi. Mikrobiyol Bul 2015;49:47-55.
  3. Abuali MM, Katariwala R, LaBombardi VJ. A comparison of the Sensititre MycoTB panel and the agar proportion method for the susceptibility testing of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis 2012;31:835-9.
  4. Bektöre B, Haznedaroğlu T, Baylan O, Ozyurt M, Özkütük N, Satana D ve ark. Çok ilaca dirençli tüberküloz izolatlarında yaygın ilaç direncinin araştırılması. Mikrobiyol Bul 2013;47:59-70.
  5. Hall L, Jude KP, Clark SL, Dionne K, Merson R, Boyer A, et al. Evaluation of the ssensititre MYCOTB MIC plate for the susceptibility testing of Mycobacterium tuberculosis complex against first and second line agents. J Clin Microbiol 2012;50:3732-4.
  6. Lee J, Armstrong DT, Ssengooba W, Park JA, Yu Y, Mumbowa F, et al. Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first and second line drugs. Antimicrob Agents Chemother 2014;58:11-8. Clinical and Laboratory Standards Institute (CLSI). Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard, 2nd Edition, 2011:34-6. Mayo Clinic. Interpretive Handbook: Susceptibility, Mycobacterium tuberculosis Complex, Second line. Test 34550. Mpagama SG, Houpt ER, Stroup S, Kumburu H, Gratz H, Kibiki GS, et al. Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania. BMC Infect Dis 2013;13:432. T.C. Sağlık Bakanlığı. Tüberküloz Tanı ve Tedavi Rehberi. Başak Ltd. Şti. Ankara, 2011. http://www.verem.org.tr/pdf/ tum-kitap.pdf Özkara Ş, Aktaş Z, Özkan S, Ecevit H. Türkiye’de Tüberkülozun Kontrolü İçin Başvuru Kitabı. 2003. T.C. Sağlık Bakanlığı Verem Savaş Daire Başkanlığı, Ankara. Baylan O. Çok ilaca dirençli tüberkülozdan sonra yaygın ilaca dirençl